身体活动和质母细胞瘤:神经瘤治疗中的范式转变
1Department of Radiation Oncology, Chongqing University Cancer Hospital, Chongqing, China.
Frontiers in oncology
|August 14, 2025
概括
身体活动通过影响瘤生物学和增强免疫反应,显示出作为质母细胞瘤 (GBM) 补充疗法的承诺. 运动可能会改善患者的生活质量和生存率,因此需要进一步研究最佳治疗方案.
科学领域:
- 神经瘤学神经瘤学
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- 质母细胞瘤 (GBM) 是一种具有侵略性的脑瘤,治疗选择有限,预后不佳.
- 目前的GBM管理策略需要互补的方法来改善患者的治疗结果.
研究的目的:
- 审查体育活动作为GBM补充疗法的新兴作用.
- 探索运动对GBM瘤生物学,免疫调节和患者生活质量的影响.
主要方法:
- 关于GBM体力活动的临床前和临床研究的文献综述.
- 对运动对分子通路,免疫细胞和GBM患者临床结果的影响分析.
主要成果:
- 运动会影响关键的GBM通路 (RTK/PI3K/Akt/mTOR,血管新生,新陈代谢).
- 身体活动可以增强抗瘤免疫力 (T细胞,NK细胞) 并减少免疫抑制 (Tregs,MDSCs).
- 有证据表明,运动可以改善认知功能,减少毒性,并延长GBM患者的存活时间.
结论:
- 身体活动作为GBM的补充疗法具有显著的潜力.
- 需要进一步的研究来确定最佳的运动方案,并将其与新型疗法相结合.
- 个性化,多omics方法对于理解运动诱导的 GBM 瘤微环境的变化至关重要.
相关概念视频
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Parkinson's Disease: Treatment
380
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
380
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K


